News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,064 Results
Type
Article (5091)
Company Profile (24)
Press Release (226949)
Multimedia
Podcasts (2)
Webinars (5)
Section
Business (82255)
Career Advice (463)
Deals (15055)
Drug Delivery (8)
Drug Development (19075)
Employer Resources (31)
FDA (3684)
Job Trends (3909)
News (120195)
Policy (7518)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (293)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (14809)
ALS (38)
Alzheimer's disease (294)
Antibody-drug conjugate (ADC) (40)
Approvals (3784)
Artificial intelligence (80)
Autoimmune disease (27)
Automation (5)
Bankruptcy (97)
Best Places to Work (2865)
Biosimilars (32)
Biotechnology (23)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (101)
Cancer (886)
Cardiovascular disease (61)
Career advice (395)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (166)
Cervical cancer (5)
Clinical research (16684)
Collaboration (353)
Compensation (371)
Complete response letters (8)
COVID-19 (311)
CRISPR (13)
C-suite (338)
Cystic fibrosis (28)
Data (1325)
Denatured (1)
Depression (21)
Diabetes (78)
Diagnostics (2115)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (31)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (35)
Earnings (42737)
Editorial (5)
Employer branding (6)
Employer resources (33)
Events (39139)
Executive appointments (425)
FDA (4422)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (340)
Gene editing (24)
Generative AI (5)
Gene therapy (102)
GLP-1 (144)
Government (423)
Guidances (197)
Healthcare (5050)
HIV (10)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (39)
Immuno-oncology (7)
Indications (16)
Infectious disease (337)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (32)
Interviews (53)
IPO (7880)
IRA (3)
Job creations (1122)
Job search strategy (361)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (106)
Leadership (5)
Legal (2340)
Liver cancer (21)
Longevity (2)
Lung cancer (92)
Lymphoma (70)
Machine learning (3)
Management (11)
Manufacturing (139)
MASH (50)
Medical device (3923)
Medtech (3933)
Mergers & acquisitions (7580)
Metabolic disorders (214)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (539)
NextGen: Class of 2026 (1674)
Non-profit (733)
Now hiring (5)
Obesity (84)
Opinion (32)
Ovarian cancer (26)
Pain (26)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (6)
Patents (51)
Patient recruitment (96)
Peanut (6)
People (25227)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (4994)
Phase 2 (7226)
Phase 3 (5789)
Pipeline (1962)
Policy (17)
Postmarket research (625)
Preclinical (1946)
Press Release (66)
Prostate cancer (57)
Psychedelics (3)
Radiopharmaceuticals (109)
Rare diseases (179)
Real estate (1886)
Recruiting (8)
Regulatory (5538)
Reports (17)
Research institute (308)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (49)
Series A (53)
Series B (54)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1017)
Stomach cancer (1)
Supply chain (13)
Tariffs (7)
The Weekly (1)
Vaccines (80)
Venture capital (9)
Weight loss (29)
Women's health (6)
Date
Today (8)
Last 7 days (146)
Last 30 days (647)
Last 365 days (8909)
2026 (785)
2025 (9036)
2024 (11031)
2023 (13196)
2022 (18677)
2021 (19685)
2020 (18242)
2019 (13210)
2018 (10209)
2017 (10002)
2016 (9157)
2015 (12123)
2014 (9589)
2013 (7709)
2012 (8333)
2011 (8797)
2010 (8635)
Location
Africa (186)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (11784)
Australia (1691)
California (3541)
Canada (1138)
China (167)
Colorado (143)
Connecticut (162)
Delaware (70)
Europe (25493)
Florida (541)
Georgia (67)
Idaho (24)
Illinois (161)
India (14)
Indiana (105)
Iowa (9)
Japan (164)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (352)
Massachusetts (2803)
Michigan (104)
Minnesota (201)
Mississippi (1)
Missouri (31)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1018)
New Mexico (5)
New York (814)
North Carolina (479)
North Dakota (4)
Northern California (1854)
Ohio (116)
Oklahoma (5)
Oregon (6)
Pennsylvania (597)
Puerto Rico (1)
Rhode Island (19)
South America (279)
South Carolina (17)
Southern California (1304)
Tennessee (61)
Texas (481)
United States (12329)
Utah (111)
Virginia (84)
Washington D.C. (17)
Washington State (297)
West Virginia (2)
Wisconsin (57)
Wyoming (1)
232,064 Results for "conmed corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
CONMED Corporation Announces First Quarter 2024 Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2024.
April 24, 2024
·
11 min read
Business
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer
CONMED Corporation announced that Patrick Beyer, President of International and Global Orthopedics, has been promoted to the newly created role of Chief Operating Officer, effective immediately.
April 24, 2024
·
3 min read
Deals
CONMED Corporation Announces Quarterly Cash Dividend - May 22, 2024
CONMED Corporation (NYSE: CNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on May 22, 2024, payable on July 5, 2024, to all shareholders of record as of June 14, 2024.
May 22, 2024
·
1 min read
Business
CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2024 after the market close on Wednesday, April 24, 2024.
April 2, 2024
·
2 min read
CONMED Corporation to Present at the BofA Securities Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, Todd W. Garner, Executive Vice President and Chief Financial Officer, and Pat Beyer, Chief Operating Officer, will present at the BofA Securities Healthcare Conference at 2:20 p.m. PT (5:20 p.m. ET) on Tuesday, May 14, 2024 in Las Vegas, NV.
May 1, 2024
·
2 min read
Business
CONMED Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
CONMED Corporation announced financial results for the fourth quarter and full-year ended December 31, 2023.
January 31, 2024
·
18 min read
CONMED Corporation to Announce Fourth Quarter 2023 Financial Results on January 31, 2024
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter 2023 after the market close on Wednesday, January 31, 2024.
January 3, 2024
·
2 min read
CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 14-15
CONMED Corporation (NYSE: CNMD) today announced that it will participate in fireside chats at the following two investor conferences in November:
October 31, 2023
·
2 min read
Press Releases
CONMED Corporation Announces Preliminary Third Quarter Financial Information
October 4, 2024
·
3 min read
Business
CONMED Corporation Announces Quarterly Cash Dividend - December 05, 2023
CONMED Corporation announced that its Board of Directors declared a quarterly cash dividend of $0.20 per share on December 4, 2023, payable on January 5, 2024, to all shareholders of record as of December 18, 2023.
December 5, 2023
·
1 min read
1 of 23,207
Next
